U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9

Go back to U.S. District Court Invalidates Amgen Patent Claims Targeting PCSK9
Regeneron (NASDAQ: REGN) Delayed: 762.81 --0 (-0%)
Previous Close $762.81    52 Week High $592.36 
Open $762.81    52 Week Low $325.35 
Day High $762.81    P/E 200.21 
Day Low $762.81    EPS $3.81 
Volume 63